The Question Is Whether To Buy Or Not To Buy Pacific Biosciences of California Inc (NASDAQ: PACB)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Pacific Biosciences of California Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Pacific Biosciences of California Inc is $393.17M. A total of 11.81 million shares were traded on the day, compared to an average of 11.34M shares.

In the most recent transaction, HENRY CHRISTIAN O sold 12,497 shares of PACB for 1.41 per share on Mar 03 ’25. After the transaction, the insider now owns 2,225,357 company shares. In a previous transaction on Mar 03 ’25, Van Oene Mark sold 6,486 shares at 1.41 per share. PACB shares that the insider owns now total 1,497,695.

Among the insiders who sold shares, Farmer Michele disposed of 2,973 shares on Mar 03 ’25 at a per-share price of $1.41. This resulted in the insider holding 184,619 shares of PACB after the transaction. In another insider transaction, MARK VAN OENE bought 6,486 shares at $1.41 per share on Mar 03 ’25.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PACB has a high of $3.70 and a low of $1.08.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PACB’s latest balance sheet shows that the firm has $1.04B in Cash & Short Term Investments as of fiscal 2021. There were $955.36M in debt and $71.71M in liabilities at the time. Its Book Value Per Share was $1.72, while its Total Shareholder’s Equity was $790.99M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PACB is Buy with a score of 3.93.

Most Popular

Related Posts